Krystal Biotech Inc (KRYS) — Capital Reinvestment Ratio
Latest as of March 2026:
0.09x
Krystal Biotech Inc (KRYS) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow ($80.38 Million) in capital expenditures ($7.15 Million). See cash generation quality of Krystal Biotech Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.09x
Capex / Operating Cash Flow
Operating Cash Flow
$80.38 Million
USD
Capital Expenditures
$7.15 Million
USD
Data as of
Mar 2026
Most recent filing
Krystal Biotech Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Krystal Biotech Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Krystal Biotech Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Krystal Biotech Inc from 2024 to 2025. For live market cap and broader valuation context, see market cap of Krystal Biotech Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $200.87 Million | $11.95 Million | ▲ +73.3% |
| 2024 | 0.03x | $123.42 Million | $4.24 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow